The white house passed a bill yesterday authorizing the first installment of $2 billion to the African AIDS fund. They also expect to give only $2 billion again next year.
www.forbes.com/personalfinance/retirement/newswire/2003/07/24/rtr1037446.html
That means the bulk of the $15 billion promised by Bush must come in the last 3 years of his 5 year plan. That doesn't make much sense as a means to handle a medical emergency. To save the most lives, most of the funding should be up front and than taper off if the problem subsides. Unless of course the full $15 billion is not in the cards and the white house is not really serious in its fight against AIDS in Africa.
There is also the problem of the high cost of patented AIDS/HIV drugs offered by the major American pharmaceutical companies. Patented drugs for AIDS therapy can cost up to $10000/person per year. At those prices it would cost close to $20 billion per year to treat 2 million people in South Africa. That's 10 times the cost of the entire fund. Now $2 billion could treat 2 million AIDS victims(even though there are over 4 million new HIV cases in South Africa each year) if generic equivalent drugs could be used. These drugs cost over 10 times less the cost of patented drugs. But only 2 or 3 African countries are allowed to sale generic drugs. So one tends to think -is the Bush's African AIDS fund a fight against AIDS in Africa or a way to fund American pharmaceutical companies?
d
www.forbes.com/personalfinance/retirement/newswire/2003/07/24/rtr1037446.html
That means the bulk of the $15 billion promised by Bush must come in the last 3 years of his 5 year plan. That doesn't make much sense as a means to handle a medical emergency. To save the most lives, most of the funding should be up front and than taper off if the problem subsides. Unless of course the full $15 billion is not in the cards and the white house is not really serious in its fight against AIDS in Africa.
There is also the problem of the high cost of patented AIDS/HIV drugs offered by the major American pharmaceutical companies. Patented drugs for AIDS therapy can cost up to $10000/person per year. At those prices it would cost close to $20 billion per year to treat 2 million people in South Africa. That's 10 times the cost of the entire fund. Now $2 billion could treat 2 million AIDS victims(even though there are over 4 million new HIV cases in South Africa each year) if generic equivalent drugs could be used. These drugs cost over 10 times less the cost of patented drugs. But only 2 or 3 African countries are allowed to sale generic drugs. So one tends to think -is the Bush's African AIDS fund a fight against AIDS in Africa or a way to fund American pharmaceutical companies?
d